rs12891713
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001080414.4(CCDC88C):c.4107G>A(p.Gln1369Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.135 in 1,613,610 control chromosomes in the GnomAD database, including 18,875 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 4915 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13960 hom. )
Consequence
CCDC88C
NM_001080414.4 synonymous
NM_001080414.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0800
Publications
12 publications found
Genes affected
CCDC88C (HGNC:19967): (coiled-coil domain containing 88C) This gene encodes a ubiquitously expressed coiled-coil domain-containing protein that interacts with the dishevelled protein and is a negative regulator of the Wnt signalling pathway. The protein encoded by this gene has a PDZ-domain binding motif in its C-terminus with which it interacts with the dishevelled protein. Dishevelled is a scaffold protein involved in the regulation of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in embryonic development, tissue maintenance, and cancer progression. Mutations in this gene cause autosomal recessive, primary non-syndromic congenital hydrocephalus; a condition characterized by excessive accumulation of cerebrospinal fluid in the ventricles of the brain. [provided by RefSeq, Jan 2013]
CCDC88C Gene-Disease associations (from GenCC):
- hydrocephalus, nonsyndromic, autosomal recessive 1Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- spinocerebellar ataxia type 40Inheritance: AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 14-91294178-C-T is Benign according to our data. Variant chr14-91294178-C-T is described in ClinVar as Benign. ClinVar VariationId is 158112.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.08 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.433 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CCDC88C | NM_001080414.4 | c.4107G>A | p.Gln1369Gln | synonymous_variant | Exon 23 of 30 | ENST00000389857.11 | NP_001073883.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CCDC88C | ENST00000389857.11 | c.4107G>A | p.Gln1369Gln | synonymous_variant | Exon 23 of 30 | 5 | NM_001080414.4 | ENSP00000374507.6 |
Frequencies
GnomAD3 genomes AF: 0.209 AC: 31805AN: 152038Hom.: 4884 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
31805
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.138 AC: 34334AN: 249262 AF XY: 0.128 show subpopulations
GnomAD2 exomes
AF:
AC:
34334
AN:
249262
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.127 AC: 185165AN: 1461454Hom.: 13960 Cov.: 32 AF XY: 0.124 AC XY: 89829AN XY: 727030 show subpopulations
GnomAD4 exome
AF:
AC:
185165
AN:
1461454
Hom.:
Cov.:
32
AF XY:
AC XY:
89829
AN XY:
727030
show subpopulations
African (AFR)
AF:
AC:
14997
AN:
33470
American (AMR)
AF:
AC:
7268
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
4043
AN:
26134
East Asian (EAS)
AF:
AC:
3111
AN:
39698
South Asian (SAS)
AF:
AC:
6183
AN:
86254
European-Finnish (FIN)
AF:
AC:
6561
AN:
53386
Middle Eastern (MID)
AF:
AC:
853
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
133803
AN:
1111668
Other (OTH)
AF:
AC:
8346
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
8022
16044
24065
32087
40109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5126
10252
15378
20504
25630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.210 AC: 31883AN: 152156Hom.: 4915 Cov.: 32 AF XY: 0.202 AC XY: 15023AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
31883
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
15023
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
18193
AN:
41462
American (AMR)
AF:
AC:
2576
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
534
AN:
3468
East Asian (EAS)
AF:
AC:
464
AN:
5186
South Asian (SAS)
AF:
AC:
330
AN:
4830
European-Finnish (FIN)
AF:
AC:
1220
AN:
10594
Middle Eastern (MID)
AF:
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8030
AN:
68000
Other (OTH)
AF:
AC:
440
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1141
2282
3422
4563
5704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
477
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Apr 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.